35
Participants
Start Date
June 30, 2014
Primary Completion Date
May 7, 2019
Study Completion Date
May 7, 2019
Pomalidomide
4 mg PO x 21 days
Cyclophosphamide
low dose cyclophosphamide 50 mg PO BID x 21 days
Dexamethasone
dexamethasone 40 mg PO weekly (or 20 mg if ≥ 75 years old).
Icahn School of Medicine at Mount Sinai, New York
Collaborators (1)
Celgene Corporation
INDUSTRY
Ajai Chari
OTHER